<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1620">
 <bold>Conclusions:</bold> This study confirms the decrease in mortality over a 3Â years follow up associated with PCC use compared to FFP in patients presenting for any type of acute bleeding. PCC should be used as a first line therapy for anticoagulation reversal of vitamin k antagonist.
</p>
